Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Reliable, non-invasive tools are needed for better vitiligo diagnosis.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Health coaching helps infertile women with PCOS improve their health and lifestyle.

General practitioners in Qassim have satisfactory knowledge of alopecia areata but need more education to address gaps and misconceptions.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Finasteride effectively treats male hair loss, with oral and topical forms improving hair growth, but oral use may have side effects.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.

Addressing body image and weight can help improve female sexual dysfunction.

Efficient PCOS screening is crucial for early detection, with lifestyle factors like fruit intake potentially aiding prevention.

Low vitamin D and ferritin levels may contribute to hair loss in women.

Androgenetic alopecia has a minor impact on the quality of life for Jordanian men.

Hormonal therapies effectively treat acne and improve quality of life.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Topical minoxidil can cause unwanted hair growth and eye issues, especially in infants, so better education and guidelines are needed.

Lifestyle changes improve symptoms and fertility in hyper-androgenic women.

Few dermatologists in Ontario accept OHIP referrals for hair loss, leading to long wait times and high fees.

SIRT3 and SIRT7 genes may play a role in hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Older age and specific haircare practices increase the risk of traction alopecia, and education on these factors could help prevent it.